Ocular toxoplasmosis in the immunocompromised host.

Area of Science:

• Ophthalmology
• Infectious Diseases
• Immunology

Background:

• Disseminated toxoplasmosis is a known complication in immunocompromised individuals.
• Ocular toxoplasmosis is less common than other organ involvement in these patients, with unclear reasons.
• Reactivation of latent toxoplasmosis may not solely depend on immunodeficiency.

Purpose of the Study:

• To review the diagnosis and management of ocular toxoplasmosis in immunocompromised patients.
• To discuss the varied clinical presentations and potential origins of ocular lesions.
• To evaluate treatment strategies and the role of anti-inflammatory drugs.

Main Methods:

• Literature review of ocular toxoplasmosis in immunocompromised hosts.
• Analysis of clinical presentations and histopathologic findings.
• Discussion of current and potential therapeutic approaches.

Main Results:

• Ocular toxoplasmosis in the immunocompromised presents diagnostic and management difficulties.
• Lesions can include retinochoroiditis, retinal necrosis, and inflammation of the iris, choroid, and vitreous.
• Most lesions may stem from acquired infections or dissemination rather than reactivation of old scars.

Conclusions:

• Standard antiparasitic therapies show promise for ocular lesions.
• Prolonged treatment is likely necessary for immunocompromised patients to prevent relapse.
• Anti-inflammatory drugs, like steroids, may have a limited role due to minimal retinal inflammation.